Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan H Barouch

Showing results (11-20 of 482) with videos related to

Pageof 49
Sort By:
Current Opinion in HIV and AIDS|May 15, 2019
Neutralizing antibodies for HIV-1 preventionBoris Julg, Dan H Barouch
Cell|April 25, 2015
Natural evolution of broadly neutralizing antibodiesGalit Alter, Dan H Barouch
Immunity|October 19, 2017
HIV-1 Latency by TransitionBoris Julg, Dan H Barouch
The Journal of Infectious Diseases|August 18, 2023
SARS-CoV-2 Hybrid Immunity: The Best of Both WorldsNinaad Lasrado, Dan H Barouch
Science (New York, N.Y.)|July 12, 2014
Immunologic strategies for HIV-1 remission and eradicationDan H Barouch, Steven G Deeks
Current HIV/AIDS Reports|February 5, 2016
Broadly Neutralizing Antibodies for HIV EradicationKathryn E Stephenson, Dan H Barouch
Annual Review of Medicine|October 5, 2021
COVID-19 Vaccines: Adenoviral VectorsCatherine Jacob-Dolan, Dan H Barouch
Current Infectious Disease Reports|January 27, 2007
HIV-1 vaccine development: progress and prospectsAnna R Thorner, Dan H Barouch
The Lancet. HIV|December 23, 2023
Prophylactic HIV-1 vaccine trials: past, present, and futureJoseph P Nkolola, Dan H Barouch
Science (New York, N.Y.)|August 18, 2022
T cell immunity to COVID-19 vaccinesE John Wherry, Dan H Barouch
Pageof 49

Showing results (11-20 of 482) with videos related to

Sort By:
Pageof 49
Current Opinion in HIV and AIDS|May 15, 2019
Neutralizing antibodies for HIV-1 preventionBoris Julg, Dan H Barouch
Cell|April 25, 2015
Natural evolution of broadly neutralizing antibodiesGalit Alter, Dan H Barouch
Immunity|October 19, 2017
HIV-1 Latency by TransitionBoris Julg, Dan H Barouch
The Journal of Infectious Diseases|August 18, 2023
SARS-CoV-2 Hybrid Immunity: The Best of Both WorldsNinaad Lasrado, Dan H Barouch
Science (New York, N.Y.)|July 12, 2014
Immunologic strategies for HIV-1 remission and eradicationDan H Barouch, Steven G Deeks
Current HIV/AIDS Reports|February 5, 2016
Broadly Neutralizing Antibodies for HIV EradicationKathryn E Stephenson, Dan H Barouch
Annual Review of Medicine|October 5, 2021
COVID-19 Vaccines: Adenoviral VectorsCatherine Jacob-Dolan, Dan H Barouch
Current Infectious Disease Reports|January 27, 2007
HIV-1 vaccine development: progress and prospectsAnna R Thorner, Dan H Barouch
The Lancet. HIV|December 23, 2023
Prophylactic HIV-1 vaccine trials: past, present, and futureJoseph P Nkolola, Dan H Barouch
Science (New York, N.Y.)|August 18, 2022
T cell immunity to COVID-19 vaccinesE John Wherry, Dan H Barouch
Pageof 49